Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Proteomics : MCP|July 5, 2014
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscleBruno Menezes de Oliveira, Cintia Y Matsumura, Cibely C Fontes-Oliveira, et al.
Plos One|January 10, 2020
Soluble AXL as a marker of disease progression and survival in melanomaKarine Flem-Karlsen, Marta Nyakas, Inger Nina Farstad, et al.
Frontiers in Oncology|November 28, 2022
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)Sólrún Melkorka Maggadóttir, Gunnar Kvalheim, Patrik Wernhoff, et al.
Human Molecular Genetics|May 27, 2005
Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of diseaseIgnacio Mazón Peláez, Susanne Vogler, Ulf Strauss, et al.
Cancers|July 2, 2020
Dysregulation of MITF Leads to Transformation in MC1R-Defective MelanocytesTimothy J Lavelle, Tine Norman Alver, Karen-Marie Heintz, et al.
Pigment Cell & Melanoma Research|October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cellsMarina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Hereditary Cancer in Clinical Practice|December 19, 2013
Mutation spectrum in South American Lynch syndrome familiesMev Dominguez-Valentin, Mef Nilbert, Patrik Wernhoff, et al.
Translational Oncology|May 17, 2019
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node MetastasesVivi Ann Flørenes, Karine Flem-Karlsen, Erin McFadden, et al.
Cancers|November 26, 2022
Genetic Characterization in High-Risk Individuals from a Low-Resource City of PeruElizabeth Zavaleta, Nelly Solis, Maria Isabel Palacios, et al.
Cell Reports. Medicine|May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemiaBenjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Pageof 3